⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Thiosulfuric Acid SCHEMBL8512498 | 0.95 | CA5A (0.50) | — | |
| Thiosulfuric Acid SCHEMBL3422841 | 0.95 | CA5A (0.50) | — | |
| Thiosulfuric Acid SCHEMBL16761679 | 0.95 | — | — | |
| Thiosulfuric Acid SCHEMBL11785568 | 0.95 | CA5A (0.50) | — | |
| Thiosulfuric Acid SCHEMBL6446 | 0.95 | — | — | |
| Thiosulfuric Acid SCHEMBL3693222 | 0.90 | — | — | |
| Thiosulfuric Acid SCHEMBL8988115 | 0.90 | — | — | |
| Thiosulfuric Acid SCHEMBL11513934 | 0.90 | — | — | |
| Thiosulfuric Acid SCHEMBL8162774 | 0.90 | CA5A (0.46) | — | |
| Thiosulfuric Acid SCHEMBL10754299 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022036259-A1 | PERSONAL ANTIMICROBIAL CARRIER | PAC X, LLC (US) | 2022-02-17 | — | — | WO | disclosed |
| US-20220047050-A1 | PERSONAL ANTIMICROBIAL CARRIER | PAC X, LLC | 2022-02-17 | — | — | US | disclosed |
| US-9480260-B2 | Acrylic polymers containing metallic nanoparticles | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2016-11-01 | — | — | US | disclosed |
| US-20140288171-A1 | ACRYLIC POLYMERS CONTAINING METALLIC NANOPARTICLES | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2014-09-25 | — | — | US | disclosed |
| US-8779023-B2 | In situ formation of nanoparticles in resins | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2014-07-15 | — | — | US | disclosed |
| US-20110306699-A1 | IN SITU FORMATION OF NANOPARTICLES IN RESINS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2011-12-15 | — | — | US | disclosed |
| WO-2010077985-A1 | IN SITU FORMATION OF NANOPARTICLES IN RESINS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2010-07-08 | — | — | WO | disclosed |
| EP-1567101-A4 | PROPHYLACTIC TREATMENT METHODS | NUCRYST PHARM CORP (CA) | 2009-06-03 | — | — | EP | disclosed |
| EP-2043611-A2 | METAL-CONTAINING FORMULATIONS AND METHODS OF USE | Nucryst Pharmaceuticals Corp. (CA) | 2009-04-08 | — | — | EP | disclosed |
| US-7427416-B2 | Methods of treating conditions using metal-containing materials | NUCRYST PHARMACEUTICALS CORP. (CA) | 2008-09-23 | — | — | US | disclosed |
| EP-1575552-A2 | METAL-CONTAINING MATERIALS, COMPOSITIONS AND METHODS | Nucryst Pharmaceuticals Corp. (CA) | 2005-09-21 | — | — | EP | disclosed |
| EP-1567101-A2 | PROPHYLACTIC TREATMENT METHODS | NUCFRYST PHARMACEUTICALS CORP. (CA) | 2005-08-31 | — | — | EP | disclosed |
| WO-2005074949-A1 | TREATMENT OF UNGUAL AND SUBUNGUAL DISEASES WITH ANTIMICROBIAL METAL COMPOSITIONS | NUCRYST PHARMACEUTICALS CORP. (CA) | 2005-08-18 | — | — | WO | disclosed |
| US-20040191329-A1 | Compositions and methods of metal-containing materials | NUCRYST PHARMACEUTICALS CORP. (CA) | 2004-09-30 | — | — | US | disclosed |
| US-20040176312-A1 | Treatment of ungual and subungual diseases | NUCRYST PHARMACEUTICALS CORP. (CA) | 2004-09-09 | — | — | US | disclosed |
| US-20040131698-A1 | Methods of treating conditions using metal-containing materials | NUCRYST PHARMACEUTICALS CORP. (CA) | 2004-07-08 | — | — | US | disclosed |
| US-20040129112-A1 | Metal-containing materials | NUCRYST PHARMACEUTICALS CORP. (CA) | 2004-07-08 | — | — | US | disclosed |
| US-20040110738-A1 | Prophylactic treatment methods | NUCRYST PHARMACEUTICALS CORP. (CA) | 2004-06-10 | — | — | US | disclosed |
| WO-2004037187-A2 | METAL-CONTAINING MATERIALS, COMPOSITIONS AND METHODS | NUCRYST PHARMACEUTICALS CORP. (CA) | 2004-05-06 | — | — | WO | disclosed |
| WO-2004037186-A2 | PROPHYLACTIC TREATMENT METHODS | NUCRYST PHARMACEUTICALS CORP. (CA) | 2004-05-06 | — | — | WO | disclosed |